S. 2948 — Introduced in Senate

II 113th CONGRESS 2d Session S. 2948 IN THE SENATE OF THE UNITED STATES November 20, 2014 Mr. Sanders introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To extend the requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to include manufacturers of generic drugs. 1. Short title This Act may be cited as the Medicaid Generic Drug Price Fairness Act. 2. Applying the Medicaid additional rebate requirement to manufacturers of generic drugs (a) In general Section 1927(c)(3)(A) of the Social Security Act (42 U.S.C. 1396r–8(c)(3)(A)) is amended— (1) in clause (ii), by striking the period and inserting ,; and (2) by adding at the end the following flush text: and shall be increased by an amount determined in the same manner as the increase in the amount of a rebate for a single source drug or an innovator multiple source drug is determined under paragraph (2). . (b) Effective date The amendments made by this section shall apply to rebate periods beginning on or after the date of enactment of this Act.